Aktienanalyse zu Nature's Sunshine Products Inc (NATR)NATRNature's Sunshine Products Inc

Nature's Sunshine Products, Inc. is a natural health and wellness company, which markets and distributes nutritional and personal care products in more than 40 countries. The Company sells its products to a sales force of independent consultants who use the products themselves or resell them to consumers. The Company has four segments: Asia, Europe, North America, and Latin America and Other. Each of the geographic segments operates under the Natures Sunshine Products and Synergy WorldWide brands. The Latin America and Other segment include its wholesale business, in which the Company sells products to various locally managed entities, independent of the Company, that it has granted distribution rights for the relevant market. The Company's line of over 800 products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. It purchases herbs and other raw materials in bulk. It operates in the Consumer Non-Cyclicals sector (PHARMACEUTICAL PREPARATIONS industry).

Nature's Sunshine Products Inc (NATR) is currently not a strong buy due to recent performance declines and earnings misses. The stock is trading at $14.21, down 32.24% year-to-date, and the RSI is at a low 29.336, indicating potential oversold conditions. However, the forward P/E ratio is a reasonable 12.6422, suggesting some value, but the recent downgrade in revenue guidance and insider selling (161.97% increase in selling activity) presents significant risks.